Precision Neuroscience’s Layer 7 Cortical Interface [Photo courtesy of Precision Neuroscience]Precision Neuroscience recently closed a $93 million funding round, the brain–computer interface (BCI) developer said in a recent financial disclosure.

精密神经科学公司的第7层皮质界面[图片由精密神经科学公司提供]精密神经科学公司最近完成了一轮9300万美元的资助，该公司的大脑-计算机接口（BCI）开发人员在最近的一份财务披露中表示。

New York City–based Precision Neuroscience said in the Securities and Exchange Commission filing that it hoped to raise up to $150 million in this latest round, and that 21 unidentified investors took part.

总部位于纽约市的精密神经科学公司（Precision Neuroscience）在美国证券交易委员会（Securities and Exchange Commission）提交的文件中表示，它希望在最新一轮融资中筹集1.5亿美元，21名身份不明的投资者参加了融资。

The equity offering disclosure was filed on Oct. 17 and listed the date of first sale as Oct. 2.

股权发行披露于10月17日提交，并将首次出售日期列为10月2日。

In January 2023, Precision Neuroscience announced its $41 million Series B funding round, led by Forepont Capital Partners.

2023年1月，Precision Neuroscience宣布了由Forepont Capital Partners牵头的4100万美元B轮融资。

The device developer has not similarly announced this latest round, and a representative reached today declined to comment, saying no information was immediately available.

这家设备开发商并没有类似地宣布这一最新一轮交易，今日达成的一位代表拒绝置评，称目前尚无相关信息。

Citing a source identified only as “a person familiar with the situation,” Bloomberg said the the round valued the company at around $500 million.

彭博社援引一位仅被确认为“知情人士”的消息人士的话说，本轮估值约为5亿美元。

The Series C round brings the device developer’s total funding somewhere near $146 million.

C系列项目为设备开发商带来了近1.46亿美元的总资金。

Also last month, Precision Neuroscience reported positive results from a pilot study of its Layer 7 Cortical Interface. The flexible, thin-film implant conforms to the surface of a patient’s brain, with embedded electrodes for  high-resolution mapping of brain activity and stimulation.

同样在上个月，精密神经科学公司（Precision Neuroscience）报告了对其第7层皮质界面的初步研究的积极结果。柔性薄膜植入物符合患者大脑表面，嵌入电极用于大脑活动和刺激的高分辨率映射。

Precision Neuroscience says the film is one-fifth the thickness of a human hair and was designed for a neurosurgeon to implant or retrieve the device without damaging brain tissue.

Precision Neuroscience表示，该薄膜的厚度是人类头发厚度的五分之一，是为神经外科医生设计的，可以在不损伤脑组织的情况下植入或取出该设备。

The implantation procedure — unlike that of Elon Musk’s Neuralink — does not require a craniotomy. Instead, physicians place the device with a new, minimally invasive “micro-slit” technique using 400-micron-wide incisions in the skull.

与埃隆·马斯克的Neuralink不同，植入手术不需要开颅手术。取而代之的是，医生用一种新的微创“微缝”技术放置该装置，该技术在颅骨中使用400微米宽的切口。

Founded by Chief Science Officer Dr. Ben Rapoport — a neurosurgeon and engineer who was among Neuralink’s co-founders — and CEO Michael Mager in 2021, Precision Neuroscience is just one of the device developers in the BCI space, which could be worth $400 billion in the U.S. alone. Another BCI developer with a different minimally invasive approach, Synchron, appears to hold the lead in the race for FDA approval..

由首席科学官Ben Rapoport博士（神经外科医生和工程师，也是Neuralink的联合创始人之一）和首席执行官Michael Mager于2021年创立，Precision Neuroscience只是BCI领域的设备开发商之一，仅在美国就可能价值4000亿美元。另一位采用不同微创方法的BCI开发人员Synchron似乎在FDA批准的竞争中领先。。

In July, Precision Neuroscience expanded its leadership team by hiring Chief Clinical and Commercial Officer Jayme Strauss and Chief Financial Officer Mike Kaswan.

7月，精密神经科学公司（Precision Neuroscience）聘请了首席临床和商业官杰姆·施特劳斯（JaymeStrauss）和首席财务官迈克·卡斯旺（MikeKaswan），扩大了其领导团队。

Read more: 5 brain-computer interface companies you should know

阅读更多：你应该知道的5家脑机接口公司